Aberrant expression of miRNAs has been implicated in various tumor types, including glioblastoma, and demonstrated to impact cancer cell proliferation, EGFR downstream signaling, as well as efficacy of several anti-EGFR-targeting therapeutic approaches. The gene discussed is EGFR; the disease is glioblastoma.